E-LIB Suche - Ergebnisse für: Monica Crugnola - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

The Italian Multicentric Randomized OPTkIMA Trial on Fixed ..:

Malagola, Michele ; Iurlo, Alessandra ; Bucelli, Cristina...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 5 - p. 323-331 , 2024

Link: https://doi.org/10.1016/..

2

Evans syndrome: Disease awareness and clinical management i..:

Fattizzo, Bruno ; Carrai, Valentina ; Crugnola, Monica...
European Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

3

S173: RETROSPECTIVE STUDY OF LENALIDOMIDE DISCONTINUATION I..:

Crisà, Elena ; Díez Campelo, María ; Germing, Ulrich...
HemaSphere. 7 (2023) S3 - p. e93218cc , 2023

Link: https://doi.org/10.1097/..

4

A Prognostic Model to Predict Ruxolitinib Discontinuation a..:

Palandri, Francesca ; Palumbo, Giuseppe A. ; Bonifacio, Massimiliano...
Cancers. 15 (2023) 20 - p. 5027 , 2023

Link: https://doi.org/10.3390/..

5

Prospective monitoring of chronic myeloid leukemia patients..:

Pacelli, Paola ; Santoni, Adele ; Sicuranza, Anna...
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

6

Determinants of Covid19 disease and of survival after Covid..:

Palandri, Francesca ; Elli, Elena M. ; Auteri, Giuseppe...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

7

Predictors of Response to Hydroxyurea and Switch to Ruxolit..:

Palandri, Francesca ; Rossi, Elena ; Auteri, Giuseppe...
Cancers. 15 (2023) 14 - p. 3706 , 2023

Link: https://doi.org/10.3390/..

8

PB2611: EVANS SYNDROME: DISEASE AWARENESS AND CLINICAL MANA..:

Fattizzo, Bruno ; Carrai, Valentina ; Crugnola, Monica...
HemaSphere. 7 (2023) S3 - p. e024400a , 2023

Link: https://doi.org/10.1097/..

9

P1686: LONG-TERM COMORBIDITY AND HEALTH PROBLEMS IN ACUTE M..:

Efficace, Fabio ; Cannella, Laura ; Thomas, Xavier...
HemaSphere. 7 (2023) S3 - p. e90211c0 , 2023

Link: https://doi.org/10.1097/..

10

Incidence of blast phase in myelofibrosis patients accordin..:

Palandri, Francesca ; Palumbo, Giuseppe A. ; Benevolo, Giulia...
Cancer. 130 (2023) 8 - p. 1270-1280 , 2023

Link: https://doi.org/10.1002/..

11

Ruxolitinib in cytopenic myelofibrosis: Response, toxicity,..:

Palandri, Francesca ; Breccia, Massimo ; Mazzoni, Camilla...
Cancer. 129 (2023) 11 - p. 1704-1713 , 2023

Link: https://doi.org/10.1002/..

12

P686: REAL-WORLD EFFICACY PROFILE OF ASCIMINIB IN AN ITALIA..:

Breccia, Massimo ; Russo Rossi, Antonella ; Giai, Valentina...
HemaSphere. 7 (2023) S3 - p. e55133e1 , 2023

Link: https://doi.org/10.1097/..

13

P1028: MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX) MO..:

Palandri, Francesca ; Auteri, Giuseppe ; Iurlo, Alessandra...
HemaSphere. 7 (2023) S3 - p. e4692509 , 2023

Link: https://doi.org/10.1097/..

14

Peripheral blasts are associated with responses to ruxoliti..:

Palandri, Francesca ; Bartoletti, Daniela ; Iurlo, Alessandra...
Cancer. 128 (2022) 13 - p. 2449-2454 , 2022

Link: https://doi.org/10.1002/..

15

Hypocellular myelodysplastic syndromes (h-MDS): from clinic..:

Calabretto, Giulia ; Attardi, Enrico ; Teramo, Antonella...
Leukemia. 36 (2022) 7 - p. 1947-1950 , 2022

Link: https://doi.org/10.1038/..

1-15